Clinical Trials Browser

Phase 1/2 × INDUSTRY × EBI-005 × Clear all

NCT04121442 2024-08-06

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult